At .50 and all the catalysts that are supposedly happening before the end of the year, what am I missing assuming that IMUC has positive results? Seems like not too heavy a premium considering the stock was almost $4.00 with half as much going on a year ago.
I think his point was that $3 isn't a good price if we are supposed to hear good new in Dec. I think hearing anything in Dec would be bad however. I'd prefer 64 not happen that soon unless of course 40 of them were placebo. If we don't hear anything before Feb then 3$ is going to be cheap.